nodes	percent_of_prediction	percent_of_DWPC	metapath
Linagliptin—type 2 diabetes mellitus—obesity	0.485	1	CtDrD
Linagliptin—DPP4—obesity	0.312	1	CbGaD
Linagliptin—CYP3A4—Sibutramine—obesity	0.0247	0.222	CbGbCtD
Linagliptin—ABCB1—Cimetidine—obesity	0.0195	0.175	CbGbCtD
Linagliptin—CYP3A4—Benzphetamine—obesity	0.0188	0.168	CbGbCtD
Linagliptin—CYP3A4—Bupropion—obesity	0.0159	0.143	CbGbCtD
Linagliptin—CYP3A4—Orlistat—obesity	0.013	0.117	CbGbCtD
Linagliptin—CYP3A4—Cimetidine—obesity	0.0117	0.105	CbGbCtD
Linagliptin—CYP3A4—Topiramate—obesity	0.00766	0.0688	CbGbCtD
Linagliptin—Alogliptin—DPP4—obesity	0.00284	1	CrCbGaD
Linagliptin—Diabetic—Orlistat—obesity	0.00179	0.0404	CcSEcCtD
Linagliptin—Diabetic—Topiramate—obesity	0.000964	0.0217	CcSEcCtD
Linagliptin—Hyperlipidaemia—Sibutramine—obesity	0.000804	0.0181	CcSEcCtD
Linagliptin—Pancreatitis acute—Topiramate—obesity	0.000697	0.0157	CcSEcCtD
Linagliptin—Pancreatitis—Cimetidine—obesity	0.000667	0.015	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Methamphetamine—obesity	0.000561	0.0127	CcSEcCtD
Linagliptin—Constipation—Methamphetamine—obesity	0.000556	0.0125	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Benzphetamine—obesity	0.000541	0.0122	CcSEcCtD
Linagliptin—Urticaria—Methamphetamine—obesity	0.000517	0.0117	CcSEcCtD
Linagliptin—Diabetes mellitus—Orlistat—obesity	0.000499	0.0113	CcSEcCtD
Linagliptin—Urticaria—Benzphetamine—obesity	0.000498	0.0112	CcSEcCtD
Linagliptin—Constipation—Phendimetrazine—obesity	0.000489	0.011	CcSEcCtD
Linagliptin—Diabetes mellitus—Sibutramine—obesity	0.000483	0.0109	CcSEcCtD
Linagliptin—Hypersensitivity—Methamphetamine—obesity	0.000479	0.0108	CcSEcCtD
Linagliptin—Hypersensitivity—Benzphetamine—obesity	0.000462	0.0104	CcSEcCtD
Linagliptin—Hyperlipidaemia—Topiramate—obesity	0.000446	0.0101	CcSEcCtD
Linagliptin—Hypoglycaemia—Orlistat—obesity	0.000445	0.01	CcSEcCtD
Linagliptin—Diarrhoea—Methamphetamine—obesity	0.000445	0.01	CcSEcCtD
Linagliptin—Hypoglycaemia—Sibutramine—obesity	0.000431	0.00972	CcSEcCtD
Linagliptin—Diarrhoea—Benzphetamine—obesity	0.000429	0.00968	CcSEcCtD
Linagliptin—Myalgia—Diethylpropion—obesity	0.000424	0.00956	CcSEcCtD
Linagliptin—Pain in extremity—Sibutramine—obesity	0.00042	0.00948	CcSEcCtD
Linagliptin—Constipation—Phenylpropanolamine—obesity	0.000418	0.00942	CcSEcCtD
Linagliptin—Headache—Methamphetamine—obesity	0.000407	0.00919	CcSEcCtD
Linagliptin—Myalgia—Cimetidine—obesity	0.000403	0.0091	CcSEcCtD
Linagliptin—Arthralgia—Cimetidine—obesity	0.000403	0.0091	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Phentermine—obesity	0.000403	0.0091	CcSEcCtD
Linagliptin—Constipation—Phentermine—obesity	0.0004	0.00901	CcSEcCtD
Linagliptin—Headache—Benzphetamine—obesity	0.000393	0.00886	CcSEcCtD
Linagliptin—Diarrhoea—Phendimetrazine—obesity	0.000391	0.00882	CcSEcCtD
Linagliptin—Anaphylactic shock—Cimetidine—obesity	0.000387	0.00872	CcSEcCtD
Linagliptin—Hypoglycaemia—Bupropion—obesity	0.000376	0.00847	CcSEcCtD
Linagliptin—DPP4—islet of Langerhans—obesity	0.000375	0.133	CbGeAlD
Linagliptin—Urticaria—Phentermine—obesity	0.000371	0.00837	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Diethylpropion—obesity	0.00037	0.00835	CcSEcCtD
Linagliptin—Pancreatitis—Orlistat—obesity	0.000368	0.0083	CcSEcCtD
Linagliptin—Pain in extremity—Bupropion—obesity	0.000367	0.00827	CcSEcCtD
Linagliptin—Hypersensitivity—Phenylpropanolamine—obesity	0.00036	0.00811	CcSEcCtD
Linagliptin—Headache—Phendimetrazine—obesity	0.000358	0.00808	CcSEcCtD
Linagliptin—DPP4—respiratory system—obesity	0.000355	0.126	CbGeAlD
Linagliptin—Musculoskeletal discomfort—Cimetidine—obesity	0.000352	0.00795	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Diethylpropion—obesity	0.000351	0.00791	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Orlistat—obesity	0.000349	0.00787	CcSEcCtD
Linagliptin—Constipation—Diethylpropion—obesity	0.000348	0.00784	CcSEcCtD
Linagliptin—Infestation NOS—Orlistat—obesity	0.000335	0.00755	CcSEcCtD
Linagliptin—Infestation—Orlistat—obesity	0.000335	0.00755	CcSEcCtD
Linagliptin—Constipation—Cimetidine—obesity	0.000331	0.00746	CcSEcCtD
Linagliptin—Weight increased—Sibutramine—obesity	0.000331	0.00746	CcSEcCtD
Linagliptin—Nasopharyngitis—Bupropion—obesity	0.000328	0.00739	CcSEcCtD
Linagliptin—Urinary tract infection—Orlistat—obesity	0.000325	0.00734	CcSEcCtD
Linagliptin—Urticaria—Diethylpropion—obesity	0.000323	0.00728	CcSEcCtD
Linagliptin—Diarrhoea—Phentermine—obesity	0.00032	0.00721	CcSEcCtD
Linagliptin—Urinary tract infection—Sibutramine—obesity	0.000315	0.0071	CcSEcCtD
Linagliptin—Pancreatitis—Bupropion—obesity	0.000311	0.00701	CcSEcCtD
Linagliptin—Rash—Phenylpropanolamine—obesity	0.000308	0.00694	CcSEcCtD
Linagliptin—Dermatitis—Phenylpropanolamine—obesity	0.000308	0.00694	CcSEcCtD
Linagliptin—Rash—Phentermine—obesity	0.000295	0.00664	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Bupropion—obesity	0.000294	0.00664	CcSEcCtD
Linagliptin—Dermatitis—Phentermine—obesity	0.000294	0.00664	CcSEcCtD
Linagliptin—Headache—Phentermine—obesity	0.000293	0.0066	CcSEcCtD
Linagliptin—Weight increased—Bupropion—obesity	0.000288	0.0065	CcSEcCtD
Linagliptin—Hypersensitivity—Cimetidine—obesity	0.000285	0.00643	CcSEcCtD
Linagliptin—Infestation—Bupropion—obesity	0.000282	0.00637	CcSEcCtD
Linagliptin—Infestation NOS—Bupropion—obesity	0.000282	0.00637	CcSEcCtD
Linagliptin—Diarrhoea—Diethylpropion—obesity	0.000278	0.00627	CcSEcCtD
Linagliptin—Urinary tract infection—Bupropion—obesity	0.000275	0.00619	CcSEcCtD
Linagliptin—DPP4—cardiovascular system—obesity	0.000272	0.0963	CbGeAlD
Linagliptin—Immune system disorder—Orlistat—obesity	0.000271	0.00612	CcSEcCtD
Linagliptin—Mediastinal disorder—Orlistat—obesity	0.000271	0.00611	CcSEcCtD
Linagliptin—Diabetes mellitus—Topiramate—obesity	0.000268	0.00606	CcSEcCtD
Linagliptin—Diarrhoea—Cimetidine—obesity	0.000265	0.00597	CcSEcCtD
Linagliptin—Immune system disorder—Sibutramine—obesity	0.000263	0.00593	CcSEcCtD
Linagliptin—Malnutrition—Orlistat—obesity	0.000262	0.0059	CcSEcCtD
Linagliptin—Rash—Diethylpropion—obesity	0.000256	0.00578	CcSEcCtD
Linagliptin—Dermatitis—Diethylpropion—obesity	0.000256	0.00578	CcSEcCtD
Linagliptin—Headache—Diethylpropion—obesity	0.000255	0.00574	CcSEcCtD
Linagliptin—Malnutrition—Sibutramine—obesity	0.000253	0.00571	CcSEcCtD
Linagliptin—Back pain—Orlistat—obesity	0.000253	0.00571	CcSEcCtD
Linagliptin—Back pain—Sibutramine—obesity	0.000245	0.00552	CcSEcCtD
Linagliptin—Rash—Cimetidine—obesity	0.000244	0.0055	CcSEcCtD
Linagliptin—Dermatitis—Cimetidine—obesity	0.000244	0.0055	CcSEcCtD
Linagliptin—Headache—Cimetidine—obesity	0.000242	0.00546	CcSEcCtD
Linagliptin—DPP4—adipose tissue—obesity	0.000239	0.085	CbGeAlD
Linagliptin—Hypoglycaemia—Topiramate—obesity	0.000239	0.0054	CcSEcCtD
Linagliptin—Angioedema—Orlistat—obesity	0.000239	0.00539	CcSEcCtD
Linagliptin—Pain in extremity—Topiramate—obesity	0.000234	0.00527	CcSEcCtD
Linagliptin—Angioedema—Sibutramine—obesity	0.000231	0.00522	CcSEcCtD
Linagliptin—Immune system disorder—Bupropion—obesity	0.000229	0.00517	CcSEcCtD
Linagliptin—Mediastinal disorder—Bupropion—obesity	0.000229	0.00515	CcSEcCtD
Linagliptin—Cough—Orlistat—obesity	0.000228	0.00515	CcSEcCtD
Linagliptin—DPP4—digestive system—obesity	0.000225	0.08	CbGeAlD
Linagliptin—Myalgia—Orlistat—obesity	0.000223	0.00502	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000221	0.00499	CcSEcCtD
Linagliptin—Cough—Sibutramine—obesity	0.000221	0.00498	CcSEcCtD
Linagliptin—Malnutrition—Bupropion—obesity	0.000221	0.00498	CcSEcCtD
Linagliptin—Arthralgia—Sibutramine—obesity	0.000216	0.00486	CcSEcCtD
Linagliptin—Myalgia—Sibutramine—obesity	0.000216	0.00486	CcSEcCtD
Linagliptin—DPP4—adrenal gland—obesity	0.000215	0.0762	CbGeAlD
Linagliptin—Anaphylactic shock—Orlistat—obesity	0.000214	0.00482	CcSEcCtD
Linagliptin—Back pain—Bupropion—obesity	0.000214	0.00482	CcSEcCtD
Linagliptin—Infection—Orlistat—obesity	0.000212	0.00478	CcSEcCtD
Linagliptin—Nasopharyngitis—Topiramate—obesity	0.000209	0.00471	CcSEcCtD
Linagliptin—Skin disorder—Orlistat—obesity	0.000207	0.00468	CcSEcCtD
Linagliptin—Anaphylactic shock—Sibutramine—obesity	0.000207	0.00466	CcSEcCtD
Linagliptin—Infection—Sibutramine—obesity	0.000205	0.00463	CcSEcCtD
Linagliptin—Angioedema—Bupropion—obesity	0.000202	0.00455	CcSEcCtD
Linagliptin—Skin disorder—Sibutramine—obesity	0.000201	0.00453	CcSEcCtD
Linagliptin—Pancreatitis—Topiramate—obesity	0.000198	0.00446	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Orlistat—obesity	0.000195	0.00439	CcSEcCtD
Linagliptin—Cough—Bupropion—obesity	0.000193	0.00434	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Sibutramine—obesity	0.000188	0.00425	CcSEcCtD
Linagliptin—Myalgia—Bupropion—obesity	0.000188	0.00424	CcSEcCtD
Linagliptin—Arthralgia—Bupropion—obesity	0.000188	0.00424	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Topiramate—obesity	0.000188	0.00423	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000187	0.00421	CcSEcCtD
Linagliptin—DPP4—endocrine gland—obesity	0.000186	0.0661	CbGeAlD
Linagliptin—Gastrointestinal disorder—Orlistat—obesity	0.000184	0.00416	CcSEcCtD
Linagliptin—Weight increased—Topiramate—obesity	0.000184	0.00414	CcSEcCtD
Linagliptin—Anaphylactic shock—Bupropion—obesity	0.00018	0.00406	CcSEcCtD
Linagliptin—Infestation NOS—Topiramate—obesity	0.00018	0.00406	CcSEcCtD
Linagliptin—Infestation—Topiramate—obesity	0.00018	0.00406	CcSEcCtD
Linagliptin—Infection—Bupropion—obesity	0.000179	0.00404	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Sibutramine—obesity	0.000178	0.00402	CcSEcCtD
Linagliptin—Constipation—Sibutramine—obesity	0.000177	0.00399	CcSEcCtD
Linagliptin—Skin disorder—Bupropion—obesity	0.000175	0.00395	CcSEcCtD
Linagliptin—Urinary tract infection—Topiramate—obesity	0.000175	0.00395	CcSEcCtD
Linagliptin—Urticaria—Orlistat—obesity	0.00017	0.00383	CcSEcCtD
Linagliptin—DPP4—liver—obesity	0.000168	0.0596	CbGeAlD
Linagliptin—Urticaria—Sibutramine—obesity	0.000164	0.0037	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Bupropion—obesity	0.000164	0.0037	CcSEcCtD
Linagliptin—Hypersensitivity—Orlistat—obesity	0.000157	0.00355	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Bupropion—obesity	0.000156	0.00351	CcSEcCtD
Linagliptin—Constipation—Bupropion—obesity	0.000154	0.00347	CcSEcCtD
Linagliptin—Hypersensitivity—Sibutramine—obesity	0.000152	0.00343	CcSEcCtD
Linagliptin—Diarrhoea—Orlistat—obesity	0.000146	0.0033	CcSEcCtD
Linagliptin—Immune system disorder—Topiramate—obesity	0.000146	0.00329	CcSEcCtD
Linagliptin—Mediastinal disorder—Topiramate—obesity	0.000146	0.00328	CcSEcCtD
Linagliptin—Urticaria—Bupropion—obesity	0.000143	0.00323	CcSEcCtD
Linagliptin—Diarrhoea—Sibutramine—obesity	0.000141	0.00319	CcSEcCtD
Linagliptin—Malnutrition—Topiramate—obesity	0.000141	0.00317	CcSEcCtD
Linagliptin—Back pain—Topiramate—obesity	0.000136	0.00307	CcSEcCtD
Linagliptin—Rash—Orlistat—obesity	0.000135	0.00304	CcSEcCtD
Linagliptin—Dermatitis—Orlistat—obesity	0.000135	0.00303	CcSEcCtD
Linagliptin—Headache—Orlistat—obesity	0.000134	0.00302	CcSEcCtD
Linagliptin—Hypersensitivity—Bupropion—obesity	0.000133	0.00299	CcSEcCtD
Linagliptin—Rash—Sibutramine—obesity	0.00013	0.00294	CcSEcCtD
Linagliptin—Dermatitis—Sibutramine—obesity	0.00013	0.00294	CcSEcCtD
Linagliptin—Headache—Sibutramine—obesity	0.000129	0.00292	CcSEcCtD
Linagliptin—Diarrhoea—Bupropion—obesity	0.000123	0.00278	CcSEcCtD
Linagliptin—Cough—Topiramate—obesity	0.000123	0.00277	CcSEcCtD
Linagliptin—Arthralgia—Topiramate—obesity	0.00012	0.0027	CcSEcCtD
Linagliptin—Myalgia—Topiramate—obesity	0.00012	0.0027	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000119	0.00268	CcSEcCtD
Linagliptin—Infection—Topiramate—obesity	0.000114	0.00257	CcSEcCtD
Linagliptin—Rash—Bupropion—obesity	0.000114	0.00256	CcSEcCtD
Linagliptin—Dermatitis—Bupropion—obesity	0.000113	0.00256	CcSEcCtD
Linagliptin—Headache—Bupropion—obesity	0.000113	0.00255	CcSEcCtD
Linagliptin—Skin disorder—Topiramate—obesity	0.000111	0.00251	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Topiramate—obesity	0.000105	0.00236	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Topiramate—obesity	9.91e-05	0.00223	CcSEcCtD
Linagliptin—Constipation—Topiramate—obesity	9.81e-05	0.00221	CcSEcCtD
Linagliptin—Urticaria—Topiramate—obesity	9.12e-05	0.00206	CcSEcCtD
Linagliptin—ABCB1—islet of Langerhans—obesity	8.67e-05	0.0307	CbGeAlD
Linagliptin—Hypersensitivity—Topiramate—obesity	8.46e-05	0.00191	CcSEcCtD
Linagliptin—ABCB1—respiratory system—obesity	8.18e-05	0.029	CbGeAlD
Linagliptin—Diarrhoea—Topiramate—obesity	7.85e-05	0.00177	CcSEcCtD
Linagliptin—CYP3A4—digestive system—obesity	7.35e-05	0.0261	CbGeAlD
Linagliptin—Rash—Topiramate—obesity	7.24e-05	0.00163	CcSEcCtD
Linagliptin—Dermatitis—Topiramate—obesity	7.23e-05	0.00163	CcSEcCtD
Linagliptin—Headache—Topiramate—obesity	7.19e-05	0.00162	CcSEcCtD
Linagliptin—ABCB1—adrenal cortex—obesity	6.87e-05	0.0244	CbGeAlD
Linagliptin—ABCB1—cardiovascular system—obesity	6.27e-05	0.0222	CbGeAlD
Linagliptin—CYP3A4—endocrine gland—obesity	6.07e-05	0.0215	CbGeAlD
Linagliptin—ABCB1—pituitary gland—obesity	5.55e-05	0.0197	CbGeAlD
Linagliptin—ABCB1—adipose tissue—obesity	5.53e-05	0.0196	CbGeAlD
Linagliptin—CYP3A4—liver—obesity	5.48e-05	0.0194	CbGeAlD
Linagliptin—ABCB1—digestive system—obesity	5.2e-05	0.0185	CbGeAlD
Linagliptin—ABCB1—adrenal gland—obesity	4.96e-05	0.0176	CbGeAlD
Linagliptin—ABCB1—endocrine gland—obesity	4.3e-05	0.0153	CbGeAlD
Linagliptin—ABCB1—liver—obesity	3.88e-05	0.0138	CbGeAlD
Linagliptin—ABCB1—Metabolism—SUCLA2—obesity	1.2e-05	0.000288	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—obesity	1.18e-05	0.000285	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—PRKAR2B—obesity	1.18e-05	0.000285	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—AKT1—obesity	1.15e-05	0.000278	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—MUT—obesity	1.14e-05	0.000275	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LIPE—obesity	1.14e-05	0.000275	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—GCK—obesity	1.11e-05	0.000268	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—DGAT1—obesity	1.09e-05	0.000264	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYB5A—obesity	1.09e-05	0.000264	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GLRX—obesity	1.09e-05	0.000263	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—CETP—obesity	1.07e-05	0.000258	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—TF—obesity	1.06e-05	0.000256	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ACLY—obesity	1.05e-05	0.000254	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—obesity	1.03e-05	0.000249	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ENPP1—obesity	1.02e-05	0.000245	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALOX12—obesity	1.02e-05	0.000245	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—TFRC—obesity	1.02e-05	0.000245	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HMGCS1—obesity	9.85e-06	0.000237	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—obesity	9.82e-06	0.000236	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—OTC—obesity	9.73e-06	0.000234	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPM1L—obesity	9.73e-06	0.000234	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ETFDH—obesity	9.73e-06	0.000234	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—INSIG2—obesity	9.73e-06	0.000234	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PLIN1—obesity	9.57e-06	0.00023	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ANGPTL4—obesity	9.57e-06	0.00023	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ACADM—obesity	9.57e-06	0.00023	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SAT1—obesity	9.57e-06	0.00023	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PNPLA2—obesity	9.57e-06	0.00023	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PFKFB3—obesity	9.57e-06	0.00023	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ACACB—obesity	9.31e-06	0.000224	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—OXCT1—obesity	9.31e-06	0.000224	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYTB—obesity	9.31e-06	0.000224	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PNLIP—obesity	9.07e-06	0.000218	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SRD5A1—obesity	9.07e-06	0.000218	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—INPP5E—obesity	8.9e-06	0.000214	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—UQCRC2—obesity	8.9e-06	0.000214	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GPT—obesity	8.9e-06	0.000214	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SDC3—obesity	8.85e-06	0.000213	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HK2—obesity	8.65e-06	0.000208	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—STS—obesity	8.65e-06	0.000208	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP26B1—obesity	8.65e-06	0.000208	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC2A4—obesity	8.65e-06	0.000208	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—CYCS—obesity	8.53e-06	0.000206	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPARD—obesity	8.47e-06	0.000204	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—obesity	8.37e-06	0.000202	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SLC27A1—obesity	8.29e-06	0.0002	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALDH6A1—obesity	8.27e-06	0.000199	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ME1—obesity	8.27e-06	0.000199	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SUCLG2—obesity	8.27e-06	0.000199	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—NCOA1—obesity	8.25e-06	0.000199	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—POMC—obesity	8.25e-06	0.000199	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GLUL—obesity	8.13e-06	0.000196	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—FABP4—obesity	8.13e-06	0.000196	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—PLG—obesity	8.04e-06	0.000194	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—COX7C—obesity	7.78e-06	0.000187	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—UCP1—obesity	7.78e-06	0.000187	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PNPLA3—obesity	7.78e-06	0.000187	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—UCP3—obesity	7.71e-06	0.000186	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ECHS1—obesity	7.71e-06	0.000186	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—UCP2—obesity	7.71e-06	0.000186	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HSD11B1—obesity	7.71e-06	0.000186	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ADH1B—obesity	7.59e-06	0.000183	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GPAM—obesity	7.47e-06	0.00018	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPARGC1B—obesity	7.47e-06	0.00018	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ACSL1—obesity	7.47e-06	0.00018	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—GNB3—obesity	7.45e-06	0.00018	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—HMOX1—obesity	7.42e-06	0.000179	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—DGAT2—obesity	7.37e-06	0.000178	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CS—obesity	7.37e-06	0.000178	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CPS1—obesity	7.37e-06	0.000178	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SUCLA2—obesity	7.37e-06	0.000178	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—GNAS—obesity	7.26e-06	0.000175	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HADH—obesity	7.25e-06	0.000175	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PCK1—obesity	7.25e-06	0.000175	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—FADS1—obesity	7.25e-06	0.000175	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—obesity	7.11e-06	0.000171	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—APOB—obesity	7.11e-06	0.000171	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	7.1e-06	0.000171	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ACP5—obesity	7.05e-06	0.00017	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—MUT—obesity	7.03e-06	0.000169	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LIPE—obesity	7.03e-06	0.000169	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—G6PD—obesity	6.87e-06	0.000166	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HK1—obesity	6.79e-06	0.000164	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SREBF2—obesity	6.79e-06	0.000164	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—DGAT1—obesity	6.74e-06	0.000162	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYB5A—obesity	6.74e-06	0.000162	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—obesity	6.63e-06	0.00016	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LPA—obesity	6.56e-06	0.000158	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ACLY—obesity	6.49e-06	0.000156	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LPIN1—obesity	6.42e-06	0.000155	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOA5—obesity	6.29e-06	0.000151	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALOX12—obesity	6.27e-06	0.000151	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ENPP1—obesity	6.27e-06	0.000151	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HMGCS1—obesity	6.07e-06	0.000146	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	6.04e-06	0.000145	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SLC22A1—obesity	6e-06	0.000144	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CLOCK—obesity	6e-06	0.000144	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—PPARA—obesity	5.99e-06	0.000144	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ACADM—obesity	5.89e-06	0.000142	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ANGPTL4—obesity	5.89e-06	0.000142	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SAT1—obesity	5.89e-06	0.000142	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PLIN1—obesity	5.89e-06	0.000142	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PNPLA2—obesity	5.89e-06	0.000142	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PFKFB3—obesity	5.89e-06	0.000142	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SULT2A1—obesity	5.84e-06	0.000141	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GLP1R—obesity	5.84e-06	0.000141	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—DPYD—obesity	5.75e-06	0.000138	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—OXCT1—obesity	5.73e-06	0.000138	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYTB—obesity	5.73e-06	0.000138	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ACACB—obesity	5.73e-06	0.000138	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—APOA1—obesity	5.62e-06	0.000135	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PNLIP—obesity	5.59e-06	0.000135	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SRD5A1—obesity	5.59e-06	0.000135	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PRKAR2B—obesity	5.53e-06	0.000133	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—DCN—obesity	5.49e-06	0.000132	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SDC3—obesity	5.45e-06	0.000131	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CPT1A—obesity	5.34e-06	0.000129	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—STS—obesity	5.33e-06	0.000128	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP26B1—obesity	5.33e-06	0.000128	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HK2—obesity	5.33e-06	0.000128	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NAMPT—obesity	5.24e-06	0.000126	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPARD—obesity	5.22e-06	0.000126	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GCK—obesity	5.21e-06	0.000125	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LIPC—obesity	5.21e-06	0.000125	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOC3—obesity	5.18e-06	0.000125	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SLC27A1—obesity	5.11e-06	0.000123	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CETP—obesity	5.02e-06	0.000121	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GLUL—obesity	5.01e-06	0.000121	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—FABP4—obesity	5.01e-06	0.000121	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SDC1—obesity	4.97e-06	0.00012	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	4.93e-06	0.000119	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—AKR1C3—obesity	4.89e-06	0.000118	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SCARB1—obesity	4.81e-06	0.000116	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—UCP3—obesity	4.75e-06	0.000114	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HSD11B1—obesity	4.75e-06	0.000114	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—UCP2—obesity	4.75e-06	0.000114	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ECHS1—obesity	4.75e-06	0.000114	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ADH1B—obesity	4.67e-06	0.000113	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SREBF1—obesity	4.67e-06	0.000113	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ACSL1—obesity	4.6e-06	0.000111	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GPAM—obesity	4.6e-06	0.000111	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPARGC1B—obesity	4.6e-06	0.000111	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GOT2—obesity	4.54e-06	0.000109	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PCK1—obesity	4.47e-06	0.000108	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—FADS1—obesity	4.47e-06	0.000108	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HADH—obesity	4.47e-06	0.000108	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ALB—obesity	4.45e-06	0.000107	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—FASN—obesity	4.45e-06	0.000107	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—BCHE—obesity	4.43e-06	0.000107	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ACP5—obesity	4.34e-06	0.000105	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP2E1—obesity	4.27e-06	0.000103	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—G6PD—obesity	4.23e-06	0.000102	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NQO1—obesity	4.22e-06	0.000102	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SREBF2—obesity	4.18e-06	0.000101	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HK1—obesity	4.18e-06	0.000101	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GCG—obesity	4.05e-06	9.76e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SLC2A4—obesity	4.05e-06	9.76e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LPA—obesity	4.04e-06	9.73e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYCS—obesity	4e-06	9.63e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LPIN1—obesity	3.95e-06	9.52e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GGT1—obesity	3.92e-06	9.45e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GOT1—obesity	3.92e-06	9.45e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOA5—obesity	3.87e-06	9.33e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NCOA1—obesity	3.86e-06	9.31e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—STK11—obesity	3.81e-06	9.17e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP19A1—obesity	3.81e-06	9.17e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SLC22A1—obesity	3.69e-06	8.9e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CLOCK—obesity	3.69e-06	8.9e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SULT2A1—obesity	3.6e-06	8.67e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GLP1R—obesity	3.6e-06	8.67e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—DPYD—obesity	3.54e-06	8.53e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—COMT—obesity	3.54e-06	8.53e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPARGC1A—obesity	3.49e-06	8.41e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GNB3—obesity	3.49e-06	8.41e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HMOX1—obesity	3.47e-06	8.37e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PRKAR2B—obesity	3.41e-06	8.21e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GNAS—obesity	3.4e-06	8.19e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—DCN—obesity	3.38e-06	8.15e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOB—obesity	3.33e-06	8.02e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CPT1A—obesity	3.29e-06	7.93e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NAMPT—obesity	3.23e-06	7.78e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LIPC—obesity	3.21e-06	7.73e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GCK—obesity	3.21e-06	7.73e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOC3—obesity	3.19e-06	7.68e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LPL—obesity	3.18e-06	7.66e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GPX1—obesity	3.1e-06	7.47e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CETP—obesity	3.1e-06	7.46e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SDC1—obesity	3.06e-06	7.37e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CD36—obesity	3.02e-06	7.28e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—AKR1C3—obesity	3.01e-06	7.26e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SCARB1—obesity	2.96e-06	7.14e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SREBF1—obesity	2.88e-06	6.93e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—MTHFR—obesity	2.86e-06	6.89e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPARA—obesity	2.81e-06	6.76e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GOT2—obesity	2.8e-06	6.74e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—FASN—obesity	2.74e-06	6.6e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—BCHE—obesity	2.73e-06	6.57e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—AGT—obesity	2.72e-06	6.55e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOE—obesity	2.66e-06	6.42e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CAV1—obesity	2.64e-06	6.36e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOA1—obesity	2.63e-06	6.34e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP2E1—obesity	2.63e-06	6.34e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NQO1—obesity	2.6e-06	6.27e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GCG—obesity	2.5e-06	6.01e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SLC2A4—obesity	2.5e-06	6.01e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYCS—obesity	2.46e-06	5.93e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GGT1—obesity	2.42e-06	5.82e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GOT1—obesity	2.42e-06	5.82e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PIK3CG—obesity	2.4e-06	5.79e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NCOA1—obesity	2.38e-06	5.73e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—STK11—obesity	2.35e-06	5.65e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP19A1—obesity	2.35e-06	5.65e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPARG—obesity	2.32e-06	5.59e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—POMC—obesity	2.29e-06	5.51e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—INS—obesity	2.28e-06	5.48e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—COMT—obesity	2.18e-06	5.25e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPARGC1A—obesity	2.15e-06	5.18e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GNB3—obesity	2.15e-06	5.18e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HMOX1—obesity	2.14e-06	5.16e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PIK3CD—obesity	2.11e-06	5.09e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GNAS—obesity	2.09e-06	5.04e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALB—obesity	2.09e-06	5.03e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOB—obesity	2.05e-06	4.94e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PIK3R1—obesity	2e-06	4.81e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NOS3—obesity	2e-06	4.81e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LPL—obesity	1.96e-06	4.72e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GPX1—obesity	1.91e-06	4.6e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CD36—obesity	1.86e-06	4.48e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PIK3CB—obesity	1.84e-06	4.44e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PTGS2—obesity	1.83e-06	4.4e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—MTHFR—obesity	1.76e-06	4.25e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPARA—obesity	1.73e-06	4.17e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—AGT—obesity	1.68e-06	4.04e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOE—obesity	1.64e-06	3.95e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CAV1—obesity	1.63e-06	3.92e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOA1—obesity	1.62e-06	3.91e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PIK3CG—obesity	1.48e-06	3.57e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPARG—obesity	1.43e-06	3.44e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—POMC—obesity	1.41e-06	3.4e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—INS—obesity	1.4e-06	3.38e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PIK3CD—obesity	1.3e-06	3.14e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALB—obesity	1.29e-06	3.1e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PIK3R1—obesity	1.23e-06	2.96e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NOS3—obesity	1.23e-06	2.96e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PIK3CB—obesity	1.14e-06	2.73e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PTGS2—obesity	1.12e-06	2.71e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PIK3CA—obesity	1.12e-06	2.71e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—AKT1—obesity	9.17e-07	2.21e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PIK3CA—obesity	6.92e-07	1.67e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—AKT1—obesity	5.65e-07	1.36e-05	CbGpPWpGaD
